Nutraceutical Contract Manufacturing Services Market Report 2026

The nutraceutical contract manufacturing services market size has grown rapidly in recent years. It will grow from $194.89 billion in 2025 to $218.34 billion in 2026 at a compound annual growth rate (CAGR) of 12%. The growth in the historic period can be attributed to growth in dietary supplement consumption, expansion of health and wellness awareness, rise in pharmaceutical outsourcing, increasing preventive healthcare focus, availability of contract manufacturing facilities.

The nutraceutical contract manufacturing services market size is expected to see rapid growth in the next few years. It will grow to $340.8 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to growth in personalized nutrition demand, increasing functional food consumption, expansion of nutraceutical brands, rising global health consciousness, advancements in formulation technologies. Major trends in the forecast period include rising outsourcing of nutraceutical production, growing demand for custom formulations, expansion of clean label manufacturing, increased focus on regulatory compliance, growth of functional food and supplement production.

The increasing prevalence of chronic diseases is expected to drive the growth of the nutraceutical contract manufacturing services market in the coming years. Chronic diseases are long-term health conditions that typically last three months or longer and often worsen over time. Nutraceutical contract manufacturing supports nutraceutical brands by enabling faster product development and scalable production of high-quality, customized nutraceutical products that can help manage and prevent chronic conditions. For example, in April 2025, according to the U.S. Centers for Disease Control and Prevention (CDC), a US-based government public health agency, 76.4% of U.S. adults were reported to have at least one chronic condition, while 51.4% had multiple chronic conditions, indicating a consistently high prevalence. Therefore, the rising burden of chronic diseases is propelling the growth of the nutraceutical contract manufacturing services market.

Companies operating in the nutraceutical contract manufacturing services market are increasingly developing innovative development and manufacturing platforms to improve profitability and operational efficiency. A nutraceutical contract manufacturing and development platform generally represents an integrated suite of outsourced services, infrastructure, and technical capabilities that support clients throughout the nutraceutical product development and manufacturing process. For instance, in November 2023, Lallemand Health Solutions, a Canada-based probiotics manufacturer, launched Expert’Biome CDMO, an advanced contract development and manufacturing platform designed to support partners in developing next-generation strains. The platform offers services including strain characterization, scale-up, synthesis, and other manufacturing processes. Its facilities comply with stringent quality standards such as cGMP Pharma and are supported by internationally recognized accreditations, ensuring high-quality investigational and commercial biological product development.

In January 2023, Sirio Pharma, a China-based contract manufacturer and developer of nutritional and dietary supplement products, acquired Best Formulations for an undisclosed amount. Through this acquisition, Sirio Pharma aims to strengthen its global footprint and enhance its ability to deliver high-quality nutraceutical products to customers worldwide, serving both international and local brands. Best Formulations is a US-based contract manufacturer specializing in nutritional supplements and personal care products.

Major companies operating in the nutraceutical contract manufacturing services market are Nutra Manufacturing Inc., Royal DSM, Lonza Group AG, Glanbia Plc., Catalent Inc., Ashland Global Holdings Inc., American Health Foundations Inc., Robinson Pharma Inc., Gemini Pharmaceuticals Inc., Nutrivo, Menadiona, NutraLab Canada Ltd., Martínez Nieto, Rain Nutrience Ltd., Biovencer Healthcare Pvt Ltd., NutraScience Labs, ABH Pharma Inc., NutraPak USA, Biotrex Nutraceuticals, Nutrafill LLC, Quest Nutra Pharma, Vestanutra.

Asia-Pacific was the largest region in the nutraceutical contract manufacturing services market in 2025. The regions covered in the nutraceutical contract manufacturing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nutraceutical contract manufacturing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nutraceutical contract manufacturing services market includes revenues earned by entities by providing formulation development, ingredient sourcing, screen printing and labeling, and quality control services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.